Anaconda Biomed secured a €20M funding round to advance its next-generation thrombectomy systems for ischemic stroke.
Anaconda Biomed S
Anaconda Biomed S.L. is a Barcelona-based medical device start-up developing next-generation endovascular access and protection, specifically designed for neurointerventions, including mechanical thrombectomy in cases of large vessel occlusion acute ischemic stroke.